Features of the of psoriatic arthritis course in patients with hyperuricemia or gout

Background. Recent studies indicate a possible link between elevated uric acid levels and a more severe course of psoria­tic arthritis (PsA), in particular, more frequent development of erosive changes. The purpose was to determine the clinical, laboratory, and radiological features of PsA in patien...

Full description

Saved in:
Bibliographic Details
Main Authors: O.P. Bortkevych, D.M. Sydorenko, O.I. Mitchenko, L.H. Voronkov, A.S. Krylova
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2025-06-01
Series:Bolʹ, Sustavy, Pozvonočnik
Subjects:
Online Access:https://pjs.zaslavsky.com.ua/index.php/journal/article/view/464
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839614946940289024
author O.P. Bortkevych
D.M. Sydorenko
O.I. Mitchenko
L.H. Voronkov
A.S. Krylova
author_facet O.P. Bortkevych
D.M. Sydorenko
O.I. Mitchenko
L.H. Voronkov
A.S. Krylova
author_sort O.P. Bortkevych
collection DOAJ
description Background. Recent studies indicate a possible link between elevated uric acid levels and a more severe course of psoria­tic arthritis (PsA), in particular, more frequent development of erosive changes. The purpose was to determine the clinical, laboratory, and radiological features of PsA in patients with hyperuricemia or gout. Materials and methods. A retrospective analysis of the medical records of 98 patients with PsA, which were divided into groups based on normo/hyperuricemia/presence of gout and type of suppurative therapy. The following parameters were analyzed: general clinical, laboratory (determination of inflammatory markers, urea level), and instrumental (X-ray examination) parameters. Methods of questionnaire and biomedical statistics were used. Results. Compared with patients with normouricemia, the hyperuricemic group was more often male (73 vs. 89 %). The number of enthesitis (anamnestic) was higher in the hyperuricemic group than in the normouricemic group (41 vs. 23 %, p = 0.04). In the first group, the erythrocyte sedimentation rate (ESR) did not exceed the normal range and was 9.00 (IQR 5.0–15.0) mm/h, in the second group it was higher (12.00 (IQR 5.0–21.5) mm/h), although statistically insignificant. The level of C-reactive protein (CRP) was statistically higher in the hyperuricemia group. Patients with gout had higher values of uric acid (median — 549.0 mmol/l), ESR (median – 16.0 mm/h) and CRP (median — 11.35 mg/l). In the hyperuricemia group, the highest radiological stage was diagnosed more often. The significant lower level of uric acid (281.0 (IQR 223.0–336.0) mmol/l) was observed in the combined group of biological and combined therapy (p = 0.049) compared with synthetic therapy. Conclusion. Patients with PsA had a frequent comorbidity with hyperuricemia and gout (30 %), which influenced the more severe course of the disease, more enthesitis, higher radiological stage and inflammation levels, which should be considered in patient ma­nagement.
format Article
id doaj-art-6f87b34b971c47bc85c45c3f64a9cfcc
institution Matheson Library
issn 2224-1507
2307-1133
language English
publishDate 2025-06-01
publisher Zaslavsky O.Yu.
record_format Article
series Bolʹ, Sustavy, Pozvonočnik
spelling doaj-art-6f87b34b971c47bc85c45c3f64a9cfcc2025-07-25T19:11:56ZengZaslavsky O.Yu.Bolʹ, Sustavy, Pozvonočnik2224-15072307-11332025-06-01152768010.22141/pjs.15.2.2025.464464Features of the of psoriatic arthritis course in patients with hyperuricemia or goutO.P. Bortkevych0https://orcid.org/0000-0002-2498-8960D.M. Sydorenko1https://orcid.org/0009-0008-0235-0318O.I. Mitchenko2https://orcid.org/0000-0001-6692-6883L.H. Voronkov3https://orcid.org/0000-0002-9339-7427A.S. Krylova4https://orcid.org/0000-0002-7953-187XStrazhesko National Scientific Center “Institute of Cardiology, Clinical and Regenerative Medicine” of NAMSU, Kyiv, UkraineStrazhesko National Scientific Center “Institute of Cardiology, Clinical and Regenerative Medicine” of NAMSU, Kyiv, UkraineStrazhesko National Scientific Center “Institute of Cardiology, Clinical and Regenerative Medicine” of NAMSU, Kyiv, UkraineStrazhesko National Scientific Center “Institute of Cardiology, Clinical and Regenerative Medicine” of NAMSU, Kyiv, UkraineShupyk National Healthcare University of Ukraine, Kyiv, UkraineBackground. Recent studies indicate a possible link between elevated uric acid levels and a more severe course of psoria­tic arthritis (PsA), in particular, more frequent development of erosive changes. The purpose was to determine the clinical, laboratory, and radiological features of PsA in patients with hyperuricemia or gout. Materials and methods. A retrospective analysis of the medical records of 98 patients with PsA, which were divided into groups based on normo/hyperuricemia/presence of gout and type of suppurative therapy. The following parameters were analyzed: general clinical, laboratory (determination of inflammatory markers, urea level), and instrumental (X-ray examination) parameters. Methods of questionnaire and biomedical statistics were used. Results. Compared with patients with normouricemia, the hyperuricemic group was more often male (73 vs. 89 %). The number of enthesitis (anamnestic) was higher in the hyperuricemic group than in the normouricemic group (41 vs. 23 %, p = 0.04). In the first group, the erythrocyte sedimentation rate (ESR) did not exceed the normal range and was 9.00 (IQR 5.0–15.0) mm/h, in the second group it was higher (12.00 (IQR 5.0–21.5) mm/h), although statistically insignificant. The level of C-reactive protein (CRP) was statistically higher in the hyperuricemia group. Patients with gout had higher values of uric acid (median — 549.0 mmol/l), ESR (median – 16.0 mm/h) and CRP (median — 11.35 mg/l). In the hyperuricemia group, the highest radiological stage was diagnosed more often. The significant lower level of uric acid (281.0 (IQR 223.0–336.0) mmol/l) was observed in the combined group of biological and combined therapy (p = 0.049) compared with synthetic therapy. Conclusion. Patients with PsA had a frequent comorbidity with hyperuricemia and gout (30 %), which influenced the more severe course of the disease, more enthesitis, higher radiological stage and inflammation levels, which should be considered in patient ma­nagement.https://pjs.zaslavsky.com.ua/index.php/journal/article/view/464seronegative spondyloarthritispsoriatic arthritisgouthyperuricemiabasic therapy
spellingShingle O.P. Bortkevych
D.M. Sydorenko
O.I. Mitchenko
L.H. Voronkov
A.S. Krylova
Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
Bolʹ, Sustavy, Pozvonočnik
seronegative spondyloarthritis
psoriatic arthritis
gout
hyperuricemia
basic therapy
title Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
title_full Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
title_fullStr Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
title_full_unstemmed Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
title_short Features of the of psoriatic arthritis course in patients with hyperuricemia or gout
title_sort features of the of psoriatic arthritis course in patients with hyperuricemia or gout
topic seronegative spondyloarthritis
psoriatic arthritis
gout
hyperuricemia
basic therapy
url https://pjs.zaslavsky.com.ua/index.php/journal/article/view/464
work_keys_str_mv AT opbortkevych featuresoftheofpsoriaticarthritiscourseinpatientswithhyperuricemiaorgout
AT dmsydorenko featuresoftheofpsoriaticarthritiscourseinpatientswithhyperuricemiaorgout
AT oimitchenko featuresoftheofpsoriaticarthritiscourseinpatientswithhyperuricemiaorgout
AT lhvoronkov featuresoftheofpsoriaticarthritiscourseinpatientswithhyperuricemiaorgout
AT askrylova featuresoftheofpsoriaticarthritiscourseinpatientswithhyperuricemiaorgout